Compare OGS & ITGR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | OGS | ITGR |
|---|---|---|
| Founded | 1906 | 1970 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Oil/Gas Transmission | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Utilities | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.7B | 2.4B |
| IPO Year | N/A | 2000 |
| Metric | OGS | ITGR |
|---|---|---|
| Price | $77.55 | $73.25 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 9 | 8 |
| Target Price | $82.72 | ★ $93.71 |
| AVG Volume (30 Days) | 469.7K | ★ 585.3K |
| Earning Date | 11-03-2025 | 10-23-2025 |
| Dividend Yield | ★ 3.48% | N/A |
| EPS Growth | ★ 11.73 | N/A |
| EPS | ★ 4.27 | 2.42 |
| Revenue | ★ $2,368,759,000.00 | $1,831,074,000.00 |
| Revenue This Year | $23.59 | $9.58 |
| Revenue Next Year | $4.35 | N/A |
| P/E Ratio | ★ $18.00 | $29.99 |
| Revenue Growth | ★ 15.06 | 9.54 |
| 52 Week Low | $66.38 | $62.00 |
| 52 Week High | $83.96 | $146.36 |
| Indicator | OGS | ITGR |
|---|---|---|
| Relative Strength Index (RSI) | 36.85 | 51.69 |
| Support Level | $76.52 | $69.12 |
| Resistance Level | $77.74 | $73.49 |
| Average True Range (ATR) | 1.31 | 1.51 |
| MACD | -0.49 | 1.05 |
| Stochastic Oscillator | 14.11 | 94.28 |
ONE Gas Inc is a regulated natural gas utility company. It is involved in the distribution and sale of natural gas to residential, commercial, industrial, and transportation consumers through its network of pipelines and service lines. Almost all of the company's revenue is derived from natural gas sales in the states of Oklahoma, Kansas, and Texas. The company controls considerable market shares in Oklahoma and Kansas.
Integer Holdings Corp is a manufacturer of medical device components used by original equipment manufacturers in the medical industry. The company also develops batteries used in nonmedical applications in the energy, military, and environmental markets. The firm organizes itself into one segment and derives its revenues from three product lines: Cardio & Vascular, Cardiac Rhythm Management & Neuromodulation and Other Markets. The company earns more than half of its revenue in the United States.